Results of a new survey detailing the attitudes of consumers toward direct-to-consumer print and television advertising for pharmaceuticals have been released by the Food and Drug Administration's Division of Drug Marketing, Advertising and Communications.
The 58-question survey, "Attitudes and Behaviors Associated with Direct-to-Consumer (DTC) Promotion of Prescription Drugs," was conducted over the phone with the cooperation of 1,081 consumers. An additional follow-up written survey, the results of which had not been released at press time, looked at consumer recognition of 12 direct-to-consumer advertising campaign.
The survey revealed that 30% of consumers who have seen a doctor in the last three months, and 39% of consumers who have not seen a doctor in the last month read none of the fine print information in print DTC drug ads. However, 70% of consumers who were "especially interested" in an advertised drug would read all of the information as opposed to the 2% to 3% who would read none of the fine print.
Advertising influenced roughly half the respondents to look for more information about the drug advertised or their personal health, but only 27% of those who had seen a doctor in the last three months and 8% of those who had not seen a doctor in the last three months were ever prompted by an advertisement to "ask a doctor about a medical condition or illness of [their] own that they had not talked to a doctor about before."
Full results of the survey, which also looked at how consumers perceived their doctors' reactions to queries about advertised prescription drugs, are available at www.fda.gov/cder/ddmac/dtcindex.htm#Q1. PR
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.